Skin Infections, Bacterial
8 clinical trials · Condition
◉ Watch Skin Infections, Bacterial
| Record | Firm | Date |
|---|---|---|
| Retapamulin Microdialysis Feasibility Study (NCT01812382) | GlaxoSmithKline | 2014-04-02 |
| ALTARGO(Retapamulin) PMS(Post-marketing Surveillance) (NCT01445600) | GlaxoSmithKline | 2012-11-01 |
| Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA (NCT00852540) | Stiefel, a GSK Company | 2009-04-01 |
| United States Pharmacovigilence Retapamulin-Prescribing (NCT01153880) | GlaxoSmithKline | 2008-12-01 |
| Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL) (NCT00684177) | GlaxoSmithKline | 2008-05-01 |
| Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. (NCT00555061) | GlaxoSmithKline | 2007-09-01 |
| Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo (NCT00133874) | GlaxoSmithKline | 2005-04-01 |
Track Skin Infections, Bacterial automatically
Every clearance here is in the API, with alerts when new ones post.